# Creatine and Glutamine in Steroid-Naive Duchenne Muscular Dystrophy

> **NCT00016653** · PHASE2,PHASE3 · COMPLETED · sponsor: **Cooperative International Neuromuscular Research Group** · enrollment: 48 (—)

## Conditions studied

- Muscular Dystrophy, Duchenne

## Interventions

- **DRUG:** Creatine Monohydrate
- **DRUG:** Glutamine

## Key facts

- **NCT ID:** NCT00016653
- **Lead sponsor:** Cooperative International Neuromuscular Research Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 48 (—)
- **Last updated:** 2011-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00016653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00016653, "Creatine and Glutamine in Steroid-Naive Duchenne Muscular Dystrophy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00016653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*